Abstract
Since many estrane and androstane derivatives exhibit cytotoxic, anti-oxidant, or anti-hormone activity, new steroidal derivatives were synthesised from appropriate estrogen or androgen precursors in order to obtain potential therapeutics for the treatment of steroid-dependent diseases. Starting from estradiol (I), 6-oxo derivatives V and VII were prepared. 17β-Salicyloyl-6-oxo derivatives VI and VIII were synthesised by the reaction of compounds V or VII with methyl salicylate in the presence of sodium. 17β-Salicyloyloxy estradiol IX was prepared from estradiol. Beckmann fragmentation of 16-oxyimino alcohols XII and XIII with methyl salicylate yielded corresponding D-seco derivatives XIV and XV. Simultaneous fragmentation and acylation of compound XII resulted in 3β-salicyloyl-D-seco derivative XVI which was also obtained from compound XIV. Anti-oxidant assays of the newly synthesised compounds V-IX, XIV, and XVI indicated a stronger capacity for hydroxyl radical scavenging, and a weaker capacity for DPPH radical scavenging, compared with the standard anti-oxidants BHA and BHT. Compounds V, XIV, and XVI showed higher or the same activity as BHT. The cytotoxicity of new compounds was evaluated against human breast and prostate carcinoma cells. Compound VI exhibited strong cytotoxicity against MDA-MB-231 cells; compound XIV exhibited strong cytotoxicity against PC-3 cell line, while compound VII moderately inhibited the growth of PC-3 cells.
[1] Al-Dabbas, M. M., Suganuma, T., Kitahara, K., Hou, D. X., & Fujii, M. (2006). Cytotoxic, antioxidant and antibacterial activities of Varthemia iphionoides Boiss. extracts. Journal of Ethnopharmacology, 108, 287–293. DOI: 10.1016/j.jep.2006.05.006. http://dx.doi.org/10.1016/j.jep.2006.05.00610.1016/j.jep.2006.05.006Search in Google Scholar PubMed
[2] Ali, H., Ahmed, N., Tessier, G., & van Lier, J. E. (2006). Synthesis and biological activities of nucleoside-estradiol conjugates. Bioorganic & Medicinal Chemistry Letters, 16, 317–319. DOI: 10.1016/j.bmcl.2005.10.004. http://dx.doi.org/10.1016/j.bmcl.2005.10.00410.1016/j.bmcl.2005.10.004Search in Google Scholar PubMed
[3] Badeau, M., Adlercreutz, H., Kaihovaara, P., & Tikkanen, M. J. (2005). Estrogen A-ring structure and antioxidative effect on lipoproteins. Journal of Steroid Biochemistry & Molecular Biology, 96, 271–278. DOI: 10.1016/j.jsbmb.2005.04.034. http://dx.doi.org/10.1016/j.jsbmb.2005.04.03410.1016/j.jsbmb.2005.04.034Search in Google Scholar PubMed
[4] Cicerale, S., Lucas, L., & Keast, R. (2010). Biological activities of phenolic compounds present in virgin olive oil. International Journal of Molecular Sciences, 11, 458–479. DOI: 10.3390/ijms11020458. http://dx.doi.org/10.3390/ijms1102045810.3390/ijms11020458Search in Google Scholar PubMed PubMed Central
[5] de Aguiar, R.B., Dickel, O. E., Cunha, R.W., Monserrat, J.M., Barros, D. M., & Martinez, P. E. (2008). Estradiol valerate and tibolone: effects upon brain oxidative stress and blood biochemistry during aging in female rats. Biogerontology, 9, 285–298. DOI: 10.1007/s10522-008-9137-7. http://dx.doi.org/10.1007/s10522-008-9137-710.1007/s10522-008-9137-7Search in Google Scholar PubMed
[6] Devraj, R., Barrett, J. F., Fernandez, J. A., Katzenellenbogen, J. A., & Cushman, M. (1996). Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates. Journal of Medicinal Chemistry, 39, 3367–3374. DOI: 10.1021/jm9602930. http://dx.doi.org/10.1021/jm960293010.1021/jm9602930Search in Google Scholar PubMed
[7] Djurendić, E., Dojčinović Vujašković, S., Sakač, M., Ajduković J., Gaković A., Kojić, V., Bogdanović, G., Klisurić, O., & Penov Gaši, K. (2011). Synthesis and biological evaluation of some new 2-oxazoline and salicylic acid derivatives. ARKIVOC, 2011(ii), 83–102. Search in Google Scholar
[8] Djurendić, E. A., Dojčinović-Vujašković, S. V., Sakač, M. N., Jovin, E. D., Kojić, V. V., Bogdanović, G. M., Klisurić, O. R., Stanković, S. M., Lazar, D. V., Fabian, L., & Penov-Gaši, K. M. (2010). X-ray structural analysis, antioxidant and cytotoxic activity of newly synthesized salicylic acid derivatives. Structural Chemistry, 21, 67–78. DOI: 10.1007/s11224-009-9524-y. http://dx.doi.org/10.1007/s11224-009-9524-y10.1007/s11224-009-9524-ySearch in Google Scholar
[9] Djurendić, E. A., Zaviš, M. P., Sakač, M. N., Čanadi, J. J., Kojić, V. V., Bogdanović, G. M., & Penov Gaši, K. M. (2009). Synthesis and antitumor activity of new D-seco and D-homo androstane derivatives. Steroids, 74, 983–988. DOI: 10.1016/j.steroids.2009.07.007. http://dx.doi.org/10.1016/j.steroids.2009.07.00710.1016/j.steroids.2009.07.007Search in Google Scholar PubMed
[10] Djurendić, E. A., Zaviš, M. P., Sakač, M. N., Kojić, V. V., Bogdanović, G. M., & Penov Gaši, K. M. (2008). Synthesis and biological evaluation of some A,D-ring modified 16,17-secoandrostane derivatives. Collection of Czechoslovak Chemical Communications, 73, 627–636. DOI: 10.1135/cccc20080627. http://dx.doi.org/10.1135/cccc2008062710.1135/cccc20080627Search in Google Scholar
[11] Erickson, K. L., Beutler, J. A., Cardellina, J. H., II, & Boyd, M. R. (1997). Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp. The Journal of Organic Chemistry, 62, 8188–8192. DOI: 10.1021/jo971556g. http://dx.doi.org/10.1021/jo971556g10.1021/jo971556gSearch in Google Scholar PubMed
[12] Etcheverry, S. B., Williams, P. A. M., Barrio, D. A., Sálice, V. C., Ferrer, E. G., & Cortizo, A. M. (2000). Synthesis, characterization and bioactivity of a new VO2+/aspirin complex. Journal of Inorganic Biochemistry, 80, 169–171. DOI: 10.1016/s0162-0134(00)00026-x. http://dx.doi.org/10.1016/S0162-0134(00)00026-X10.1016/S0162-0134(00)00026-XSearch in Google Scholar
[13] Fujimori, T., Yamada, S., Yasui, H., Sakurai H., In, Y., & Ishida, T. (2005). Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations. Journal of Biological Inorganic Chemistry, 10, 931–941. DOI: 10.1007/s00775-005-0031-3. 10.1007/s00775-005-0031-3Search in Google Scholar
[14] Fujisawa, S., Atsumi, T., Kadoma, Y., & Sakagami, H. (2002). Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology, 177, 39–54. DOI: 10.1016/s0300-483x(02)00194-4. http://dx.doi.org/10.1016/S0300-483X(02)00194-410.1016/S0300-483X(02)00194-4Search in Google Scholar
[15] Jones, G. B., Hynd, G., Wright, J. M., Purohit, A., Plourde, G. W., II, Huber, R. S., Mathews, J. E., Li, A., Kilgore, M. W., Bubley, G. J., Yancisin, M., & Brown, M. A. (2001). Targetdirected enediynes: Designed estramycins. The Journal of Organic Chemistry, 66, 3688–3695. DOI: 10.1021/jo0055842. http://dx.doi.org/10.1021/jo005584210.1021/jo0055842Search in Google Scholar
[16] Jovanović-Šanta, S. S., Andrić, S., Andrić, N., Bogdanović, G., & Petrović, J. A. (2011). Evaluation of biological activity of new hemiesters of 17-hydroxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile. Medicinal Chemistry Research, 20, 1102–1110. DOI: 10.1007/s00044-010-9442-y. http://dx.doi.org/10.1007/s00044-010-9442-y10.1007/s00044-010-9442-ySearch in Google Scholar
[17] Jovanović-Šanta, S., Petrović, J., Andrić, S., Kovačević, R., Đurendić, E., Sakač, M., Lazar, D., & Stanković, S. (2003). Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives. Bioorganic Chemistry, 31, 475–484. DOI: 10.1016/s0045-2068(03)00101-9. http://dx.doi.org/10.1016/S0045-2068(03)00101-910.1016/S0045-2068(03)00101-9Search in Google Scholar
[18] Kasiotis, K. M., Magiatis, P., Pratsinis, H., Skaltsounis, A. L., Abadji, V., Charalambous, A., Moutsatsou, P., & Haroutounian, S. A. (2001). Synthesis and biological evaluation of novel daunorubicin-estrogen conjugates. Steroids, 66, 785–791. DOI: 10.1016/s0039-128x(01)00110-6. http://dx.doi.org/10.1016/S0039-128X(01)00110-610.1016/S0039-128X(01)00110-6Search in Google Scholar
[19] Klinger, W., Lupp, A., Karge, E., Baumbach, H., Eichhorn, F., Feix, A., Füldner, F., Gernhardt, S., Knels, L., Kost, B., Mertens, G., Werner, F., Oettel, M., Römer, W., Schwarz, S., Elger, W., & Schneider, B. (2002). Estradiol, testosterone, dehydroepiandrosterone and androstenedione: novel derivatives and enantiomers. Interactions with rat liver microsomal cytochrome P450 and antioxidant/radical scavenger activities in vitro. Toxicology Letters, 128, 129–144. DOI: 10.1016/s0378-4274(01)00540-9. http://dx.doi.org/10.1016/S0378-4274(01)00540-910.1016/S0378-4274(01)00540-9Search in Google Scholar
[20] Liu, C., Strobl, J. S., Bane, S., Schilling, J. K., McCracken, M., Chatterjee, S. K., Rahim-Bata, R., & Kingston, D. G. I. (2004). Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer. Journal of Natural Products, 67, 152–159. DOI: 10.1021/np030296x. http://dx.doi.org/10.1021/np030296x10.1021/np030296xSearch in Google Scholar PubMed
[21] Ljubuncic, P., Azaizeh, H., Portnaya, I., Cogan, U., Said, O., Abu Saleh, K., & Bomzon, A. (2005). Antioxidant activity and cytotoxicity of eight plants used in traditional Arab medicine in Israel. Journal of Ethnopharmacology, 99, 43–47. DOI: 10.1016/j.jep.2005.01.060. http://dx.doi.org/10.1016/j.jep.2005.01.06010.1016/j.jep.2005.01.060Search in Google Scholar PubMed
[22] Logrado, L. P. L., Silveira, D., Romeiro, L. A. S., de Moraes, M. O., Cavalcanti, B. C., Costa-Lotufo, L. V., do Ó Pessoa, C., & dos Santos, M. L. (2005). Synthesis and biological evaluation of new salicylate macrolactones from anacardic acids. Journal of the Brazilian Chemical Society, 16, 1217–1225. DOI: 10.1590/s0103-50532005000700020. http://dx.doi.org/10.1590/S0103-5053200500070002010.1590/S0103-50532005000700020Search in Google Scholar
[23] Longwell, B., & Wintersteiner, O. (1940). Estrogens with oxygen in ring B. III. 6-keto-α-estradiol. The Journal of Biological Chemistry, 133, 219–229. 10.1016/S0021-9258(18)73379-6Search in Google Scholar
[24] Miljković, D., Petrović, J., Stajić, M., & Miljković, M. (1973). The Beckmann fragmentation reaction of some α-hydroxy ketoximes. The Journal of Organic Chemistry, 38, 3585–3588. DOI: 10.1021/jo00960a031. http://dx.doi.org/10.1021/jo00960a03110.1021/jo00960a031Search in Google Scholar
[25] Mimica-Dukic, N., Bozin, B., Sokovic, M., & Simin, N. (2004). Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. Journal of Agricultural and Food Chemistry, 52, 2485–2489. DOI: 10.1021/jf030698a. http://dx.doi.org/10.1021/jf030698a10.1021/jf030698aSearch in Google Scholar
[26] Ott, I., Schmidt, K., Kircher, B., Schumacher, P., Wiglenda, T., & Gust, R. (2005). Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: Studies on the mode of drug action. Journal of Medicinal Chemistry, 48, 622–629. DOI: 10.1021/jm049326z. http://dx.doi.org/10.1021/jm049326z10.1021/jm049326zSearch in Google Scholar
[27] Pejanović, V. M., Petrović, J. A., Csanádi, J. J., Stanković S. M., & Miljković, D. A. (1995). Synthesis and unusual Beckmann fragmentation reaction of syn-3-methoxy-6α,l7β-dihydroxyestra-1,3,5(10)-trien-7-one oxime. Tetrahedron, 51, 13379–13384. DOI: 10.1016/0040-4020(95)00871-5. http://dx.doi.org/10.1016/0040-4020(95)00871-510.1016/0040-4020(95)00871-5Search in Google Scholar
[28] Penov Gaši, K., Cvjetićanin, S., Stojanović, S., Kuhajda, K., Stupavsky, L., Čanadi, J., Molnar-Gabor, D., Medić-Mijačević, L., & Sakač, M. (2000). The chemical transformation of 3β,17β-dihydroxy-16-oximino-5-androstene. Acta Periodica Technologica, 31, 675–683. Search in Google Scholar
[29] Penov Gaši, K. M., Miljković, D. A., Medić-Mijačević, L. D., Djurendić, E. A., Stojanović, S. Z., Sakač, M. N, Djurendić, M. D., Stanković, S. M., Lazar, D., Andrić, S., & Kovačević, R. (2003a). Synthesis, X-ray crystal structures and biological activity of 16-amino-17-substituted-D-homo steroid derivatives. Steroids, 68, 667–676. DOI: 10.1016/s0039-128x(03)00097-7. http://dx.doi.org/10.1016/S0039-128X(03)00097-710.1016/S0039-128X(03)00097-7Search in Google Scholar
[30] Penov Gaši, K. M., Stanković, S. M., Csanádi, J. J., Djurendić, E. A., Sakač, M. N., Medić Mijačević, L., Arcson, O. N., Stojanović, S. Z., Andrić, S., Molnar Gabor, D., & Kovačević, R. (2001). New D-modified androstane derivatives as aromatase inhibitors. Steroids, 66, 645–653. DOI: 10.1016/s0039-128x(01)00096-4. http://dx.doi.org/10.1016/S0039-128X(01)00096-410.1016/S0039-128X(01)00096-4Search in Google Scholar
[31] Penov-Gaši, K., Stojanović, S., Sakač, M., Djurendić, E., Jovanović-Šanta, S., Stanković, S., Andrić, N., & Popsavin, M. (2003b). Synthesis, crystal structure and antiaromatase activity of 17-halo-16,17-seco-5-androstene derivatives. Journal of Serbian Chemical Society, 68, 707–714. http://dx.doi.org/10.2298/JSC0310707P10.2298/JSC0310707PSearch in Google Scholar
[32] Rontu, R., Solakivi, T., Teisala, K., Lehtimäki, T., Punnonen, R., & Jokela, H. (2004). Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation. Free Radical Research, 38, 129–137. DOI: 10.1080/10715760310001641169. http://dx.doi.org/10.1080/1071576031000164116910.1080/10715760310001641169Search in Google Scholar PubMed
[33] Rotem, R., Tzivony, Y., & Flescher, E. (2000). Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance. The Prostate, 42, 172–180. DOI: 10.1002/(SICI)1097-0045(20000215)42:3〈172::AID-PROS2〉3.0.CO;2-R. http://dx.doi.org/10.1002/(SICI)1097-0045(20000215)42:3<172::AID-PROS2>3.0.CO;2-R10.1002/(SICI)1097-0045(20000215)42:3<172::AID-PROS2>3.0.CO;2-RSearch in Google Scholar
[34] Sadeghi-Aliabadi, H., & Brown, J. (2004). Synthesis, analysis and biological evaluation of novel steroidal estrogenic prodrugs for the treatment of breast cancer. Pharmaceutical Biology, 42, 367–373. DOI: 10.1080/13880200490519686. http://dx.doi.org/10.1080/1388020049051968610.1080/13880200490519686Search in Google Scholar
[35] Sakač, M., Gaković, A., Stojanović, S., Djurendić, E., Kojić, V., Bogdanović, G., & Penov Gaši, K. (2008). Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives. Bioorganic Chemisty, 36, 128–132. DOI: 10.1016/j.bioorg.2008.01.002. http://dx.doi.org/10.1016/j.bioorg.2008.01.00210.1016/j.bioorg.2008.01.002Search in Google Scholar
[36] Sakač, M. N., Miljković, D. A., Penov Gaši, K. M., Popsavin, M., Klisurić, O. R., Stanković, S. M., Andrić, S., & Kovačević, R. (2005a). Synthesis, X-ray crystal structure and antiestrogenic activity of 17-methyl-16,17-secoestra-1,3,5(10)-triene derivatives. Collection of Czechoslovak Chemical Communications, 70, 63–71. DOI: 10.1135/cccc20050063. http://dx.doi.org/10.1135/cccc2005006310.1135/cccc20050063Search in Google Scholar
[37] Sakač, M. N., Penov Gaši, K. M., Popsavin, M., Djurendić, E. A., Andrić, S., & Kovačević, R. M. (2005b). Synthesis and estrogenic activity screening of some 6,9-disubstituted estradiol derivatives. Collection of Czechoslovak Chemical Communications, 70, 479–486. DOI: 10.1135/cccc20050479. http://dx.doi.org/10.1135/cccc2005047910.1135/cccc20050479Search in Google Scholar
[38] Sestili, P., Diamantini, G., Bedini, A., Cerioni, L., Tommasini, I., Tarzia, G., & Cantoni, O. (2002). Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an ironchelating mechanism. Biochemical Journal, 364, 121–128. 10.1042/bj3640121Search in Google Scholar
[39] Shuvalova, S. D., Men’shova, N. I., & Grinenko, G. S. (1983). Synthesis of estradiol esters from estrone. Pharmaceutical Chemistry Journal, 17, 663–664. DOI: 10.1007/bf00764184. http://dx.doi.org/10.1007/BF0076418410.1007/BF00764184Search in Google Scholar
[40] Shwaery, G. T., Vita, J. A., & Keaney, J. F., Jr. (1998). Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol. Atherosclerosis, 138, 255–262. DOI: 10.1016/s0021-9150(98)00020-3. http://dx.doi.org/10.1016/S0021-9150(98)00020-310.1016/S0021-9150(98)00020-3Search in Google Scholar
[41] Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute, 82, 1107–1112. DOI: 10.1093/jnci/82.13.1107. http://dx.doi.org/10.1093/jnci/82.13.110710.1093/jnci/82.13.1107Search in Google Scholar
[42] Stodola, F. H., Kendall, E. C., & McKenzie, B. F. (1941). Studies on steroid α-ketols. II. A new partial synthesis of 5-androstene-3,16,17-triol: an intermediate in the preparation of 16-hydroxytestosterone. The Journal of Organic Chemistry, 6, 841–844. DOI: 10.1021/jo01206a008. http://dx.doi.org/10.1021/jo01206a00810.1021/jo01206a008Search in Google Scholar
[43] Vedder, H., Anthes, N., Stumm, G., Würz, C., Behl, C., & Krieg, J. C. (1999). Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. Journal of Neurochemistry, 72, 2531–2538. DOI: 10.1046/j.1471-4159.1999.0722531.x. http://dx.doi.org/10.1046/j.1471-4159.1999.0722531.x10.1046/j.1471-4159.1999.0722531.xSearch in Google Scholar PubMed
© 2012 Institute of Chemistry, Slovak Academy of Sciences
